Waldeyer's ring marginal zone B cell lymphoma: Are the clinical and prognostic features nodal or extranodal? A study by the Consortium for Improving Survival of Lymphoma (CISL)

International Journal of Hematology

Volumn 96, Issue 5, 2012, Pages 631-637

  Oh, Sung Yong ^a   Kim, Won Seog ^b   Kim, Jin Seok ^b,c   Kim, Seok Jin ^a   Lee, Suee ^a   Lee, Dae Ho ^d   Lee, Soon Il ^e   Kang, Hye Jin ^f   Choi, Chul Won ^g   Park, Jinny ^h   Song, Moo Kon ⁱ   Kim, Hyo Jung ^a   Kwon, Jung Hye ^j   Kwak, Jae Yong ^k   Bae, Sung Hwa ^l   Park, Byeong Bae ^m   Do, Young Rok ⁿ   Lee, Ho Sup ^o   Jeong, Seong Hyun ^p   Suh, Cheolwon ^d   Kim, Hyo Jin ^j   more..

^a Dong A University College of Medicine   (South Korea)

^b Sungkyunkwan University School of Medicine   (South Korea)

^c Yonsei University College of Medicine   (South Korea)

^d University of Ulsan College of Medicine   (South Korea)

^e Dankook University College of Medicine   (South Korea)

^f Korea Institute of Radiation and Medical Science   (South Korea)

^g Korea University Ansan Hospital   (South Korea)

^h Gachon University College of Medicine   (South Korea)

ⁱ Pusan National University   (South Korea)

^j Hallym University Medical Center   (South Korea)

^k Chonbuk National University Medical School   (South Korea)

^l Catholic University of Daegu   (South Korea)

^m Hanyang University College of Medicine   (South Korea)

ⁿ Dongsan Medical Center   (South Korea)

^o Kosin University   (South Korea)

^p Ajou University School of Medicine   (South Korea)

more..

Author keywords

Lymphoma; Marginal zone; Waldeyer's ring

Indexed keywords

CYCLOPHOSPHAMIDE; DOXORUBICIN; PREDNISONE; RITUXIMAB; VINCRISTINE;

ADOLESCENT; ADULT; AGED; ARTICLE; CANCER COMBINATION CHEMOTHERAPY; CANCER PROGNOSIS; CANCER RADIOTHERAPY; CANCER REGRESSION; CANCER STAGING; CANCER SURGERY; CANCER SURVIVAL; CLINICAL FEATURE; DISEASE SEVERITY; FEMALE; HISTOPATHOLOGY; HUMAN; MAJOR CLINICAL STUDY; MALE; MARGINAL ZONE LYMPHOMA; MEDIAN TIME TO PROGRESSION; ONCOLOGICAL PARAMETERS; OVERALL SURVIVAL; RETROSPECTIVE STUDY; TONSIL CANCER; WALDEYER RING; WALDEYER RING MARGINAL ZONE B CELL LYMPHOMA;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CYCLOPHOSPHAMIDE; DISEASE-FREE SURVIVAL; DOXORUBICIN; FEMALE; FOLLOW-UP STUDIES; HUMANS; LYMPHOMA, B-CELL, MARGINAL ZONE; MALE; MIDDLE AGED; PREDNISONE; RETROSPECTIVE STUDIES; SURVIVAL RATE; TONSILLAR NEOPLASMS; VINCRISTINE;

EID: 84872180016     PISSN: 09255710     EISSN: 18653774     Source Type: Journal    
DOI: 10.1007/s12185-012-1200-0     Document Type: Article

References (22)

1. Tan LH. Lymphomas involving Waldeyer's ring: placement, paradigms, peculiarities, pitfalls, patterns and postulates. Ann Acad Med Singap. 2004;33:15-26.
2. Wright DH. Lymphomas of Waldeyer's ring. Histopathology. 1994;24:97-9.
3. Krol AD, le Cessie S, Snijder S, Kluin-Nelemans JC, Kluin PM, Noordijk EM. Primary extranodal non-Hodgkin's lymphoma (NHL): the impact of alternative definitions tested in the Comprehensive Cancer Centre West population-based NHL registry. Ann Oncol. 2003;14:131-9.
4. Yuen A, Jacobs C. Lymphomas of the head and neck. Semin Oncol. 1999;26:338-45.
5. Nathu RM, Mendenhall NP, Almasri NM, Lynch JW. Non- Hodgkin's lymphoma of the head and neck: a 30-year experience at the University of Florida. Head Neck. 1999;21:247-54.
6. Ezzat AA, Ibrahim EM, El Weshi AN, Khafaga YM, AlJurf M, Martin JM, et al. Localized non-Hodgkin's lymphoma of Waldeyer's ring: clinical features, management, and prognosis of 130 adult patients. Head Neck. 2001;23:547-58.
7. Menarguez J, Mollejo M, Carrion R, Oliva H, Bellas C, Forteza J, et al. Waldeyer ring lymphomas. A clinicopathological study of 79 cases. Histopathology. 1994;24:13-22.
8. Banfi A, Bonadonna G, Ricci SB, Milani F, Molinari R, Monfardini S, et al. Malignant lymphomas of Waldeyer's ring: natural history and survival after radiotherapy. Br Med J. 1972;3:140-3.
9. Solomides CC, Miller AS, Christman RA, Talwar J, Simpkins H. Lymphomas of the oral cavity: histology, immunologic type, and incidence of Epstein-Barr virus infection. Hum Pathol. 2002;33:153-7.
10. Pu X, Qi X, Ready JM. Allenes in asymmetric catalysis: asymmetric ring opening of meso-epoxides catalyzed by allene-containing phosphine oxides. J Am Chem Soc. 2009;131:10364-5.
11. Groves FD, Linet MS, Travis LB, Devesa SS. Cancer surveillance series: non-Hodgkin's lymphoma incidence by histologic subtype in the United States from 1978 through 1995. J Natl Cancer Inst. 2000;92:1240-51.
12. Oh SY, Ryoo BY, Kim WS, Park YH, Kim K, Kim HJ, et al. Nongastric marginal zone B-cell lymphoma: analysis of 247 cases. Am J Hematol. 2007;82:446-52.
13. Paulsen J, Lennert K. Low-grade B-cell lymphoma of mucosaassociated lymphoid tissue type in Waldeyer's ring. Histopathology. 1994;24:1-11.
14. Zucca E, Conconi A, Pedrinis E, Cortelazzo S, Motta T, Gospodarowicz MK, et al. Nongastric marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue. Blood. 2003;101:2489-95.
15. Qi SN, Li YX, Wang H, Wang WH, Jin J, Song YW, et al. Diffuse large B-cell lymphoma: clinical characterization and prognosis of Waldeyer ring versus lymph node presentation. Cancer. 2009;115:4980-9.
16. Gospodarowicz MK, Sutcliffe SB, Brown TC, Chua T, Bush RS. Patterns of disease in localized extranodal lymphomas. J Clin Oncol. 1987;5:875-80.
17. Ree HJ, Rege VB, Knisley RE, Thayer WR, D'Amico RP, Song JY, et al. Malignant lymphoma of Waldeyer's ring following gastrointestinal lymphoma. Cancer. 1980;46:1528-35.
18. Bertoni F, Sanna P, Tinguely M, Roggero E, Conconi A, Gisi M, et al. Association of gastric and Waldeyer's ring lymphoma: a molecular study. Hematol Oncol. 2000;18:15-9.
19. Oh SY, Kwon HC, Kim WS, Park YH, Kim K, Kim HJ, et al. Nongastric marginal zone B-cell lymphoma: a prognostic model from a retrospective multicenter study. Cancer Lett. 2007;258: 90-7.
20. Ferreri AJ, Zucca E. Marginal-zone lymphoma. Crit Rev Oncol Hematol. 2007;63:245-56.
21. Mazloom A, Medeiros LJ, McLaughlin PW, Reed V, Cabanillas FF, Fayad LE, et al. Marginal zone lymphomas: factors that affect the final outcome. Cancer. 2010;116:4291-8.
22. Oh SY, Ryoo BY, Kim WS, Kim K, Lee J, Kim HJ, et al. Nodal marginal zone B-cell lymphoma: analysis of 36 cases. Clinical presentation and treatment outcomes of nodal marginal zone B-cell lymphoma. Ann Hematol. 2006;85:781-6.